Vanguard Battery Technology Powers FIRSTGREEN Industries’ Innovative MiniZ Electric Loader

Vanguard Battery Technology Powers FIRSTGREEN Industries' Innovative MiniZ Electric Loader GlobeNewswire October 21, 2025 Milwaukee, WI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Briggs & Stratton is showcasing the power and durability of its Vanguard(TM) 48V 7kWh(1) Commercial Battery (Fi7.0) through a real-world application with its partner FIRSTGREEN Industries, an innovator in electric heavy equipment. The […]

Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy

Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy GlobeNewswire October 21, 2025 WELLESLEY HILLS, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that it has strengthened its leadership team with

SynOx Therapeutics Strengthens Board of Directors with Leading Experts in Commercialisation and Corporate Development Amid Continued Corporate Progress

SynOx Therapeutics Strengthens Board of Directors with Leading Experts in Commercialisation and Corporate Development Amid Continued Corporate Progress Charles “Chip” Romp and Tom Heyman join SynOx's Board, bringing deep launch, lifecycle, and corporate development expertise as the company advances its next-generation therapy emactuzumab toward key regulatory and commercial milestones GlobeNewswire October 21, 2025 DUBLIN and

Billy Goat Unveils Next-Generation Hurricane(TM) Stand-On Blowers: The Z3002 and X3002

Billy Goat Unveils Next-Generation Hurricane(TM) Stand-On Blowers: The Z3002 and X3002 GlobeNewswire October 21, 2025 Milwaukee, WI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Billy Goat is pleased to announce the launch of the new Z3002 and X3002 Hurricane(TM) Stand-On Blowers. These models are built upon the robust performance of the prior 3001 series, incorporating significant

Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis

Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis GlobeNewswire October 21, 2025 SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosis Topline data expected in mid-2026 WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE)

Chipmind launches from stealth with $2.5m for its AI agents to speed chip making

Chipmind launches from stealth with $2.5m for its AI agents to speed chip making Chipmind's technology is designed to shorten chip development cycles. Its AI agents solve real-world chip design and verification tasks autonomously, helping engineers save 40% of their time on repetitive low-level tasks. GlobeNewswire October 21, 2025 Zurich, Oct. 21, 2025 (GLOBE NEWSWIRE)

MPDV positioned as a Leader in the 2025 SPARK Matrix(TM): Manufacturing Execution Systems (MES)- Discrete by QKS Group

MPDV positioned as a Leader in the 2025 SPARK Matrix(TM): Manufacturing Execution Systems (MES)- Discrete by QKS Group GlobeNewswire October 21, 2025 Pune, India, Oct. 21, 2025 (GLOBE NEWSWIRE) — The QKS Group SPARK Matrix(TM) provides competitive analysis & ranking of the leading Manufacturing Execution Systems (MES)-Discrete vendors. MPDV, with its comprehensive technology and customer

Dwolla to Showcase Instant Payments at Money20/20, Ushering in the Real-Time Era of Digital Finance

Dwolla to Showcase Instant Payments at Money20/20, Ushering in the Real-Time Era of Digital Finance GlobeNewswire October 21, 2025 DES MOINES, Iowa, Oct. 21, 2025 (GLOBE NEWSWIRE) — Dwolla, a leading provider of account-to-account (A2A) payment infrastructure trusted by fintechs and enterprises, today announced its participation at Money20/20 USA, where the company will spotlight its

Q32 Bio Announces Completion of Enrollment in Part B of SIGNAL-AA Phase 2a Clinical Trial of Bempikibart for Alopecia Areata

SIGNAL-AA Part B exceeded target enrollment based on demand from patients; trial size increased to 33 patients — Q32 Bio Inc. (NASDAQ: QTTB) (“Q32 Bio”), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, today announced that it has completed enrollment in Part B

YieldMax(R) ETFs Announces Weekly Distributions for Group 1 ETFs

CHICAGO and MILWAUKEE and NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — YieldMax(R) ETFs announced distributions for the YieldMax(R) Group 1 weekly pay ETFs. Group 1 Distribution Announcement Ex. & Record Date: October 22, 2025Payment Date: October 23, 2025 ETF Ticker1 ETF Name Distribution Frequency Distribution per Share Distribution Rate2,4 30-DaySEC Yield3 ROC5 CHPY YieldMax(R)

Scroll to Top